Literature DB >> 8095253

M.D.M.A. ("Ecstasy"); a case of possible drug-induced psychosis.

H Williams1, D Meagher, P Galligan.   

Abstract

3, 4, Methylenedioxymetamphetamine (M.D.M.A., Ecstasy) is a modified amphetamine with stimulant and hallucinogenic properties. Ecstasy has been increasingly abused in Dublin in recent years. It is commonly perceived by users as a safe drug. We report a case of prolonged psychosis following brief recreational use of Ecstasy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8095253     DOI: 10.1007/bf02942900

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  8 in total

1.  Ecstasy and the dance of death.

Authors:  J A Henry
Journal:  BMJ       Date:  1992-07-04

2.  'Ecstasy' psychosis and flashbacks.

Authors:  F J Creighton; D L Black; C E Hyde
Journal:  Br J Psychiatry       Date:  1991-11       Impact factor: 9.319

3.  Chronic paranoid psychosis after misuse of MDMA ("ecstasy")

Authors:  P McGuire; T Fahy
Journal:  BMJ       Date:  1991-03-23

4.  Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users.

Authors:  S J Peroutka; H Newman; H Harris
Journal:  Neuropsychopharmacology       Date:  1988-12       Impact factor: 7.853

Review 5.  Studies of MDMA-induced neurotoxicity in nonhuman primates: a basis for evaluating long-term effects in humans.

Authors:  G A Ricaurte
Journal:  NIDA Res Monogr       Date:  1989

6.  MDMA: further evidence that its action in the medial prefrontal cortex is mediated by the serotonergic system.

Authors:  H S Pan; R Y Wang
Journal:  Brain Res       Date:  1991-01-25       Impact factor: 3.252

7.  'Eve' and 'Ecstasy'. A report of five deaths associated with the use of MDEA and MDMA.

Authors:  G P Dowling; E T McDonough; R O Bost
Journal:  JAMA       Date:  1987-03-27       Impact factor: 56.272

8.  Incidence of recreational use of 3,4-methylenedimethoxymethamphetamine (MDMA, "ecstasy") on an undergraduate campus.

Authors:  S J Peroutka
Journal:  N Engl J Med       Date:  1987-12-10       Impact factor: 91.245

  8 in total
  5 in total

1.  Persistent Psychosis After a Single Ingestion of "Ecstasy" (MDMA).

Authors:  Ankit Patel; Toby Moreland; Fasiha Haq; Fatima Siddiqui; Melissa Mikul; Huma Qadir; Shakeel Raza
Journal:  Prim Care Companion CNS Disord       Date:  2011

Review 2.  Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users.

Authors:  D I Quinn; A Wodak; R O Day
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

Review 3.  The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs.

Authors:  H Kalant
Journal:  CMAJ       Date:  2001-10-02       Impact factor: 8.262

Review 4.  Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy').

Authors:  U D McCann; S O Slate; G A Ricaurte
Journal:  Drug Saf       Date:  1996-08       Impact factor: 5.606

5.  Symptomatological features of patients with and without Ecstasy use during their first psychotic episode.

Authors:  Fabio Rugani; Silvia Bacciardi; Luca Rovai; Matteo Pacini; Angelo Giovanni Icro Maremmani; Joseph Deltito; Liliana Dell'osso; Icro Maremmani
Journal:  Int J Environ Res Public Health       Date:  2012-06-27       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.